201 results
Page 9 of 11
8-K
EX-99
5hks6o
26 Oct 06
Results of Operations and Financial Condition
12:00am
8-K
EX-99
fu8074a
22 Aug 06
Theravance Announces Positive Results In Phase 3 Telavancin Complicated Skin and Skin Structure Infection Program
12:00am
8-K
EX-99
fbj4siult8ak6ay3a
27 Jul 06
Results of Operations and Financial Condition
12:00am
CORRESP
0hkpe6 dckk
9 Jun 06
Correspondence with SEC
12:00am
8-K
EX-99
wp72 c5xvfzid
27 Apr 06
Results of Operations and Financial Condition
12:00am
CORRESP
tg1 vr81lq5y4
13 Apr 06
Correspondence with SEC
12:00am
8-K
EX-99
r1jk7tryhyt84
9 Feb 06
Results of Operations and Financial Condition
12:00am
424B5
c0tx hv4o2
2 Feb 06
Prospectus supplement for primary offering
12:00am
S-3ASR
EX-10.1
9v9 wg3vuh8a
30 Jan 06
Automatic shelf registration
12:00am
8-K
EX-99.1
ka575sy9o
30 Jan 06
Regulation FD Disclosure
12:00am
S-3ASR
zr2 s8wh0u2zyt3zb4
30 Jan 06
Automatic shelf registration
12:00am
8-K
EX-99
b864ikur6ht5a 92ootu
27 Oct 05
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
sa5ids7pnk4yys6225
27 Jul 05
Theravance Reports Second Quarter 2005 Financial Results
12:00am